Exact Mass: 456.3352

Exact Mass Matches: 456.3352

Found 62 metabolites which its exact mass value is equals to given mass value 456.3352, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Citranaxanthin

(3E,5E,7E,9E,11E,13E,15E,17Z,19E)-5,9,14,18-tetramethyl-20-(2,6,6-trimethylcyclohex-1-en-1-yl)icosa-3,5,7,9,11,13,15,17,19-nonaen-2-one

C33H44O (456.3392)


Citranaxanthin is found in citrus. Citranaxanthin is a constituent of Sinton citrangequat (a Citrus-Poncirus-Fortunella hybrid) Citranaxanthin is a carotenoid pigment used as a food additive under the E number E161i as a food coloring. There are natural sources of citranaxanthin, but it is generally prepared synthetically. It is used as an animal feed additive to impart a yellow color to chicken fat and egg yolks. Constituent of Sinton citrangequat (a Citrus-Poncirus-Fortunella hybrid)

   

N-Docosahexaenoyl Lysine

6-amino-2-(docosa-4,7,10,13,16,19-hexaenamido)hexanoic acid

C28H44N2O3 (456.3352)


N-docosahexaenoyl lysine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Lysine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Lysine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Lysine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

20alpha-dimethylamino-16beta-hydroxy-3-senecioylamino-5alpha-pregn-2-en-4-one|pachysamine N

20alpha-dimethylamino-16beta-hydroxy-3-senecioylamino-5alpha-pregn-2-en-4-one|pachysamine N

C28H44N2O3 (456.3352)


   
   

labdanyl galactoside

labdanyl galactoside

C26H48O6 (456.3451)


   

sarsaligenine B

sarsaligenine B

C28H44N2O3 (456.3352)


   

Ile Ile Ile Val

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-3-methylpentanamido]-3-methylbutanoic acid

C23H44N4O5 (456.3312)


   

Ile Ile Leu Val

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-4-methylpentanamido]-3-methylbutanoic acid

C23H44N4O5 (456.3312)


   

Ile Ile Val Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-3-methylbutanamido]-3-methylpentanoic acid

C23H44N4O5 (456.3312)


   

Ile Ile Val Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-3-methylbutanamido]-4-methylpentanoic acid

C23H44N4O5 (456.3312)


   

Ile Leu Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-3-methylpentanamido]-3-methylbutanoic acid

C23H44N4O5 (456.3312)


   

Ile Leu Leu Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-4-methylpentanamido]-3-methylbutanoic acid

C23H44N4O5 (456.3312)


   

Ile Leu Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-3-methylbutanamido]-3-methylpentanoic acid

C23H44N4O5 (456.3312)


   

Ile Leu Val Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-3-methylbutanamido]-4-methylpentanoic acid

C23H44N4O5 (456.3312)


   

Ile Val Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-methylpentanamido]-3-methylpentanoic acid

C23H44N4O5 (456.3312)


   

Ile Val Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-methylpentanamido]-4-methylpentanoic acid

C23H44N4O5 (456.3312)


   

Ile Val Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-4-methylpentanamido]-3-methylpentanoic acid

C23H44N4O5 (456.3312)


   

Ile Val Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-4-methylpentanamido]-4-methylpentanoic acid

C23H44N4O5 (456.3312)


   

Leu Ile Ile Val

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-3-methylpentanamido]-3-methylbutanoic acid

C23H44N4O5 (456.3312)


   

Leu Ile Leu Val

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-4-methylpentanamido]-3-methylbutanoic acid

C23H44N4O5 (456.3312)


   

Leu Ile Val Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-3-methylbutanamido]-3-methylpentanoic acid

C23H44N4O5 (456.3312)


   

Leu Ile Val Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-3-methylbutanamido]-4-methylpentanoic acid

C23H44N4O5 (456.3312)


   

Leu Leu Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-3-methylpentanamido]-3-methylbutanoic acid

C23H44N4O5 (456.3312)


   

Leu Leu Leu Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-4-methylpentanamido]-3-methylbutanoic acid

C23H44N4O5 (456.3312)


   

Leu Leu Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-3-methylbutanamido]-3-methylpentanoic acid

C23H44N4O5 (456.3312)


   

Leu Leu Val Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-3-methylbutanamido]-4-methylpentanoic acid

C23H44N4O5 (456.3312)


   

Leu Val Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-methylpentanamido]-3-methylpentanoic acid

C23H44N4O5 (456.3312)


   

Leu Val Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-methylpentanamido]-4-methylpentanoic acid

C23H44N4O5 (456.3312)


   

Leu Val Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-4-methylpentanamido]-3-methylpentanoic acid

C23H44N4O5 (456.3312)


   

Leu Val Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-4-methylpentanamido]-4-methylpentanoic acid

C23H44N4O5 (456.3312)


   

Val Ile Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-3-methylpentanamido]-3-methylpentanoic acid

C23H44N4O5 (456.3312)


   

Val Ile Ile Leu

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-3-methylpentanamido]-4-methylpentanoic acid

C23H44N4O5 (456.3312)


   

Val Ile Leu Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-4-methylpentanamido]-3-methylpentanoic acid

C23H44N4O5 (456.3312)


   

Val Ile Leu Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-4-methylpentanamido]-4-methylpentanoic acid

C23H44N4O5 (456.3312)


   

Val Leu Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-3-methylpentanamido]-3-methylpentanoic acid

C23H44N4O5 (456.3312)


   

Val Leu Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-3-methylpentanamido]-4-methylpentanoic acid

C23H44N4O5 (456.3312)


   

Val Leu Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-4-methylpentanamido]-3-methylpentanoic acid

C23H44N4O5 (456.3312)


   

Val Leu Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-4-methylpentanamido]-4-methylpentanoic acid

C23H44N4O5 (456.3312)


   

Citranaxanthin

(3E,5E,7E,9E,11E,13E,15E,17Z,19E)-5,9,14,18-tetramethyl-20-(2,6,6-trimethylcyclohex-1-en-1-yl)icosa-3,5,7,9,11,13,15,17,19-nonaen-2-one

C33H44O (456.3392)


D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

   

Byrsonic acid

3R,7R-diacetoxy-docosanoic acid

C26H48O6 (456.3451)


   

ascr#35

19R-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-2E-icosenoic acid

C26H48O6 (456.3451)


An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,19R)-19-hydroxyicos-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.

   

oscr#35

20-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-2E-icosanoic acid

C26H48O6 (456.3451)


An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E)-20-hydroxyicos-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.

   

Dequalinium

Dequalinium

C30H40N4+2 (456.3253)


G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AC - Quinoline derivatives D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AH - Quinoline derivatives R - Respiratory system > R02 - Throat preparations > R02A - Throat preparations > R02AA - Antiseptics C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D000890 - Anti-Infective Agents

   

(2E)-20-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]icos-2-enoic acid

(2E)-20-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]icos-2-enoic acid

C26H48O6 (456.3451)


   

Ethanaminium, N-[4-[bis[4-(diethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-

Ethanaminium, N-[4-[bis[4-(diethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-

C31H42N3+ (456.3379)


   

(2E,19R)-19-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]eicos-2-enoic acid

(2E,19R)-19-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]eicos-2-enoic acid

C26H48O6 (456.3451)


   

N-Docosahexaenoyl Lysine

N-Docosahexaenoyl Lysine

C28H44N2O3 (456.3352)


   

[3-carboxy-2-[(Z)-17-carboxyheptadec-9-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(Z)-17-carboxyheptadec-9-enoyl]oxypropyl]-trimethylazanium

C25H46NO6+ (456.3325)


   

[3-carboxy-2-[(E)-17-carboxyheptadec-9-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-17-carboxyheptadec-9-enoyl]oxypropyl]-trimethylazanium

C25H46NO6+ (456.3325)


   

[3-carboxy-2-[(E)-17-carboxyheptadec-11-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-17-carboxyheptadec-11-enoyl]oxypropyl]-trimethylazanium

C25H46NO6+ (456.3325)


   

[3-carboxy-2-[(10E,12E)-9-hydroperoxyoctadeca-10,12-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(10E,12E)-9-hydroperoxyoctadeca-10,12-dienoyl]oxypropyl]-trimethylazanium

C25H46NO6+ (456.3325)


   

[3-carboxy-2-[(9E,11E)-13-hydroperoxyoctadeca-9,11-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(9E,11E)-13-hydroperoxyoctadeca-9,11-dienoyl]oxypropyl]-trimethylazanium

C25H46NO6+ (456.3325)


   

3,7,11,15-Tetramethylhexadecane-1,2,3-triol triacetate

3,7,11,15-Tetramethylhexadecane-1,2,3-triol triacetate

C26H48O6 (456.3451)


   

[1-carboxy-3-[2-hydroxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-hydroxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]propyl]-trimethylazanium

C25H46NO6+ (456.3325)


   

TG(23:0)

TG(4:0_6:0_13:0)

C26H48O6 (456.3451)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

NA-Lys 22:6(4Z,7Z,10Z,13Z,16Z,19Z)

NA-Lys 22:6(4Z,7Z,10Z,13Z,16Z,19Z)

C28H44N2O3 (456.3352)


   
   

(6s)-6-[(2s,4s,6s,10s)-2,4,6,10-tetrahydroxyhenicosyl]-5,6-dihydropyran-2-one

(6s)-6-[(2s,4s,6s,10s)-2,4,6,10-tetrahydroxyhenicosyl]-5,6-dihydropyran-2-one

C26H48O6 (456.3451)


   

(2s,3r,4s,5s,6r)-2-{[(3s,6e)-3,7-dimethyloctadeca-1,6-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(3s,6e)-3,7-dimethyloctadeca-1,6-dien-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H48O6 (456.3451)


   

n-[(1s,2s,3as,3br,5ar,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-2-hydroxy-9a,11a-dimethyl-6-oxo-1h,2h,3h,3ah,3bh,4h,5h,5ah,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]-3-methylbut-2-enimidic acid

n-[(1s,2s,3as,3br,5ar,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-2-hydroxy-9a,11a-dimethyl-6-oxo-1h,2h,3h,3ah,3bh,4h,5h,5ah,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]-3-methylbut-2-enimidic acid

C28H44N2O3 (456.3352)


   

n-{1-[1-(dimethylamino)ethyl]-2-hydroxy-9a,11a-dimethyl-6-oxo-1h,2h,3h,3ah,3bh,4h,5h,5ah,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}-3-methylbut-2-enimidic acid

n-{1-[1-(dimethylamino)ethyl]-2-hydroxy-9a,11a-dimethyl-6-oxo-1h,2h,3h,3ah,3bh,4h,5h,5ah,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}-3-methylbut-2-enimidic acid

C28H44N2O3 (456.3352)


   

6-(2,4,6,10-tetrahydroxyhenicosyl)-5,6-dihydropyran-2-one

6-(2,4,6,10-tetrahydroxyhenicosyl)-5,6-dihydropyran-2-one

C26H48O6 (456.3451)